Suspected posaconazole toxicity in a pediatric oncology patient

Pediatric Blood and Cancer

Volumn 62, Issue 9, 2015, Pages 1682-

  Martino, Jessica ^a   Fisher, Brian T ^a   Bosse, Kristopher R ^b   Bagatell, Rochelle ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CISPLATIN; DOXORUBICIN; HEMOGLOBIN; METHOTREXATE; POSACONAZOLE; POTASSIUM; VORICONAZOLE; ANTIFUNGAL AGENT; DELAYED RELEASE FORMULATION; TRIAZOLE DERIVATIVE;

ADOLESCENT; ANEMIA; ANOREXIA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHILDHOOD CANCER; CONIOTHYRIUM FUCKELII SINUS INFECTION; DECREASED APPETITE; DELAYED RELEASE FORMULATION; DISEASE COURSE; DRUG ABSORPTION; FATIGUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOKALEMIA; INVASIVE CANDIDIASIS; LETTER; MAXILLA SINUS TUMOR; MUSCULOSKELETAL PAIN; MYCOSIS; NAUSEA; OSTEOSARCOMA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SUSPENSION; TREATMENT DURATION; CHEMICALLY INDUCED; DRUG COMBINATION; MAXILLARY SINUS NEOPLASMS; MEDICATION ERROR; MULTIMODALITY CANCER THERAPY; MYCOSES; POSTOPERATIVE COMPLICATIONS; SINUSITIS;

ADOLESCENT; ANOREXIA; ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; HUMANS; HYPOKALEMIA; MAXILLARY SINUS NEOPLASMS; MEDICATION ERRORS; MUSCULOSKELETAL PAIN; MYCOSES; OSTEOSARCOMA; POSTOPERATIVE COMPLICATIONS; SINUSITIS; TRIAZOLES;

EID: 84938485274     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25568     Document Type: Letter

References (2)

1. Noxafil® [package insert]. Whitehouse Station, NJ: Merck & Co., Inc; 2014.
2. Posaconazole dose depends on dosage form. Institute for Safe Medication Practices Newsletter. May 22, 2014.